Liu Wang, Li Yanjie, An Yuanyuan, Zhao Ruoyu, Wei Chenxi, Ren Xiaobin, He Hongbing
Department of Periodontology, Kunming Medical University School and Hospital of Stomatology, Kunming, 650106, People's Republic of China.
Yunnan Key Laboratory of Stomatology, Kunming, 650106, People's Republic of China.
J Inflamm Res. 2024 Apr 15;17:2271-2284. doi: 10.2147/JIR.S454694. eCollection 2024.
Periodontitis is an inflammatory disease that eventually destroys tooth-supporting tissue. Yunnan Baiyao (YNBY), a traditional Chinese medicine compound with haemostatic and anti-inflammatory properties has shown therapeutic potential in several diseases. Our previous study revealed that YNBY suppressed osteoclast differentiation in periodontitis. The purpose of this study is to investigate the influences of YNBY on osteoblasts and explore its potential mechanisms.
A rat periodontitis model was established by ligation of maxillary second molars. After the end of modelling, histopathological observation by hematoxylin-eosin (HE) staining and Masson trichrome staining, detection of bone resorption by Micro-CT scanning, detection of osteoclasts by tartrate-resistant acid phosphatase (TRAP) staining, expression of osteocalcin (OCN) and microtubule-associated protein 1 light chain 3 (LC3) by immunohistochemistry. Lipopolysaccharides was used to irritate MC3T3-E1 osteoblastic cells and ex vivo calvarial organ as an in vitro model of inflammation. CCK-8 assay was performed to examine the toxicity of YNBY to MC3T3-E1 osteoblastic cells. Osteogenesis was assessed with alizarin red staining, immunofluorescence staining, Western blot and immunohistochemical staining. Transmission electron microscopy, fluorescent double staining, Western blot and immunohistochemical staining were employed to detect autophagy.
Histological and micro-CT analyses revealed that YNBY gavage reduced bone loss caused by experimental periodontitis and upregulated osteogenic proteins in vivo. YNBY attenuated the production of autophagy-related proteins in periodontitis rats. Additionally, YNBY promoted osteogenesis by inhibiting inflammation-induced autophagy in vitro. Furthermore, YNBY suppressed LPS-mediated bone resorption and promoted the production of osteoblast-related proteins in inflamed calvarial tissues ex vivo.
This study demonstrated, through in vivo, in vitro and ex vivo experiments, that YNBY promoted osteoblast differentiation by suppressing autophagy, which markedly alleviated bone destruction caused by periodontitis.
牙周炎是一种最终会破坏牙齿支持组织的炎症性疾病。云南白药(YNBY)是一种具有止血和抗炎特性的中药复方,已在多种疾病中显示出治疗潜力。我们之前的研究表明,云南白药可抑制牙周炎中的破骨细胞分化。本研究旨在探讨云南白药对成骨细胞的影响并探索其潜在机制。
通过结扎上颌第二磨牙建立大鼠牙周炎模型。建模结束后,采用苏木精-伊红(HE)染色和马松三色染色进行组织病理学观察,通过显微CT扫描检测骨吸收,用抗酒石酸酸性磷酸酶(TRAP)染色检测破骨细胞,用免疫组织化学检测骨钙素(OCN)和微管相关蛋白1轻链3(LC3)的表达。使用脂多糖刺激MC3T3-E1成骨细胞和离体颅骨器官作为炎症的体外模型。采用CCK-8法检测云南白药对MC3T3-E1成骨细胞的毒性。用茜素红染色、免疫荧光染色、蛋白质免疫印迹法和免疫组织化学染色评估成骨作用。采用透射电子显微镜、荧光双染、蛋白质免疫印迹法和免疫组织化学染色检测自噬。
组织学和显微CT分析显示,云南白药灌胃减少了实验性牙周炎引起的骨丢失,并上调了体内的成骨蛋白。云南白药减弱了牙周炎大鼠自噬相关蛋白的产生。此外,云南白药在体外通过抑制炎症诱导的自噬促进成骨。此外,云南白药抑制脂多糖介导的骨吸收,并促进离体炎症颅骨组织中成骨细胞相关蛋白的产生。
本研究通过体内、体外和离体实验证明,云南白药通过抑制自噬促进成骨细胞分化,从而显著减轻牙周炎引起的骨破坏。